Jane Street’s abrdn Life Sciences Investors HQL Stock Holding History

Jane Street’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$243K	Sell	14,937 -1,699	-10%	-$28.4K	﹤0.01%	9693
2025 Q4	$279K	Buy	16,636 +2,665	+19%	+$44.8K	﹤0.01%	9001
2025 Q3	$217K	Buy	+13,971	New	+$191K	﹤0.01%	9524
2025 Q1	–	Sell	-22,098	Closed	-$290K	–	9902
2024 Q4	$290K	Buy	+22,098	New	+$319K	﹤0.01%	7787

Other funds holding HQL

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Jane Street's HQL Position: Q1 2026 in Review

Jane Street reduced its abrdn Life Sciences Investors (HQL) stake by 10% in Q1 2026, selling an estimated $28.4K and leaving 14,937 shares worth $243K. The position accounts for ﹤0.01% of the portfolio, ranked #9693.

Jane Street first reported a position in HQL in Q4 2024 and has held it in 4 quarters since. The position peaked at $290K in Q4 2024. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.

Jane Street held 14,937 shares of abrdn Life Sciences Investors worth $243K as of Q1 2026.
Jane Street sold 1,699 abrdn Life Sciences Investors shares in Q1 2026, an estimated $28.4K.
abrdn Life Sciences Investors made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #9693 holding.
Jane Street first reported a position in abrdn Life Sciences Investors in Q4 2024 and has held it in 4 quarters since.
Jane Street's abrdn Life Sciences Investors position peaked at $290K in Q4 2024.
86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.